PSY17 REAL-WORLD COST DIFFERENCE IN PATIENTS WITH PSORIASIS NEWLY INITIATING APREMILAST VS. BIOLOGIC TREATMENT AFTER CONVENTIONAL SYSTEMIC THERAPY: A RETROSPECTIVE ANALYSIS OF GERMAN SICKNESS FUND DATA
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2645
https://www.valueinhealthjournal.com/article/S1098-3015(19)35023-5/fulltext
Title :
PSY17 REAL-WORLD COST DIFFERENCE IN PATIENTS WITH PSORIASIS NEWLY INITIATING APREMILAST VS. BIOLOGIC TREATMENT AFTER CONVENTIONAL SYSTEMIC THERAPY: A RETROSPECTIVE ANALYSIS OF GERMAN SICKNESS FUND DATA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)35023-5&doi=10.1016/j.jval.2019.09.2645
First page :
Section Title :
Open access? :
No
Section Order :
12322